Literature DB >> 19225097

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

A Fenoll1, J J Granizo, L Aguilar, M J Giménez, L Aragoneses-Fenoll, G Hanquet, J Casal, D Tarragó.   

Abstract

Temporal trends of serotypes from invasive pneumococcal disease (IPD) in Spain from 1979 to September 2007 under antibiotic and vaccine pressure were analyzed. A significant trend in pneumococcal conjugate 7-valent vaccine (PCV7) serotypes (except serotype 4) was found, whereby the prevalence increased from the early 1980s and decreased in the 2000s for all but serotype 23F, which began decreasing in the late 1980s. Among the major non-PCV7 serotypes, a significant decrease was observed for serotypes 1, 5, and 7F in the 1980s. From the late 1990s, serotypes 1, 5, 6A, 7F, and 19A increased significantly, while serotypes 3 and 8 showed similar but nonsignificant trends over time. The incidence of IPD cases was 10.7/100,000 for the period 1996 to 2006, with reporting coverage ranging from 18% to 43%. A significant decrease in IPD incidence due to PCV7 serotypes was observed, while the incidence of non-PCV7 serotypes increased, with the consequence that there was no clear pattern in the overall incidence of IPD. Penicillin nonsusceptibility was correlated with the proportion of PCV7 serotypes. Erythromycin nonsusceptibility increased in association with long-half-life macrolide consumption and then decreased in 2004 to 2007. The increase in PCV7 serotypes and antibiotic nonsusceptibility related to antibiotic consumption in the 1980s and 1990s was reversed in the 2000s, probably as a result of PCV7 immunization. The decrease in IPD incidence due to PCV7 serotypes was mirrored by an increase in that of non-PCV7 serotypes. The impact of various preventive/therapeutic strategies on pneumococcal evolution is serotype dependent, and the dynamics remain unpredictable.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225097      PMCID: PMC2668361          DOI: 10.1128/JCM.01454-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Antimicrobial susceptibility and pneumococcal serotypes.

Authors:  A Fenoll; G Asensio; I Jado; S Berrón; M T Camacho; M Ortega; J Casal
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?

Authors:  Matthew R Moore; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

3.  Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).

Authors:  J J Granizo; L Aguilar; J Casal; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

4.  Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

Authors:  César García-Rey; Lorenzo Aguilar; Fernando Baquero; Julio Casal; Rafael Dal-Ré
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

5.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

6.  Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

Authors:  C A Ihekweazu; D A B Dance; R Pebody; R C George; M D Smith; P Waight; H Christensen; K A V Cartwright; J M Stuart
Journal:  Epidemiol Infect       Date:  2007-10-26       Impact factor: 2.451

7.  Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Authors:  Matthew R Moore; Robert E Gertz; Robyn L Woodbury; Genevieve A Barkocy-Gallagher; William Schaffner; Catherine Lexau; Kenneth Gershman; Arthur Reingold; Monica Farley; Lee H Harrison; James L Hadler; Nancy M Bennett; Ann R Thomas; Lesley McGee; Tamara Pilishvili; Angela B Brueggemann; Cynthia G Whitney; James H Jorgensen; Bernard Beall
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

8.  Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR.

Authors:  D Tarragó; A Fenoll; D Sánchez-Tatay; L A Arroyo; C Muñoz-Almagro; C Esteva; W P Hausdorff; J Casal; I Obando
Journal:  Clin Microbiol Infect       Date:  2008-09       Impact factor: 8.067

9.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

10.  Streptococcus pneumoniae serotype 19A in children, South Korea.

Authors:  Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more
  75 in total

1.  Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.

Authors:  Asunción Fenoll; Lorenzo Aguilar; María-José Giménez; María-Dolores Vicioso; Olga Robledo; Juan-José Granizo; Pilar Coronel
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

Review 2.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

3.  Sequetyping: serotyping Streptococcus pneumoniae by a single PCR sequencing strategy.

Authors:  Marcus H Leung; Kevin Bryson; Kathrin Freystatter; Bruno Pichon; Giles Edwards; Bambos M Charalambous; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

4.  Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Authors:  J Picazo; J Ruiz-Contreras; J Casado-Flores; E Giangaspro; F Del Castillo; T Hernández-Sampelayo; E Otheo; F Balboa; E Ríos; C Méndez
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

5.  Serotype and genotype replacement among macrolide-resistant invasive Pneumococci in adults: mechanisms of resistance and association with different transposons.

Authors:  Laura Calatayud; Carmen Ardanuy; Fe Tubau; Dora Rolo; Immaculada Grau; Román Pallarés; Rogelio Martín; Josefina Liñares
Journal:  J Clin Microbiol       Date:  2010-02-10       Impact factor: 5.948

6.  Characterization of invasive Pneumococci of serogroup 6 from adults in Barcelona, Spain, in 1994 to 2008.

Authors:  Dora Rolo; Carmen Ardanuy; Laura Calatayud; Román Pallares; Immaculada Grau; Ernesto García; Asunción Fenoll; Rogelio Martín; Josefina Liñares
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

7.  Penicillin susceptibility breakpoints for Streptococcus pneumoniae and their effect on susceptibility categorisation in Germany (1997-2013).

Authors:  M Imöhl; R R Reinert; P M Tulkens; M van der Linden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-15       Impact factor: 3.267

8.  Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.

Authors:  Fabio Cafini; Jose Yuste; Maria-Jose Giménez; David Sevillano; Lorenzo Aguilar; Luis Alou; Elisa Ramos-Sevillano; Martha Torrico; Natalia González; Ernesto García; Pilar Coronel; Jose Prieto
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

9.  Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Authors:  Gerwin D Rodenburg; Sabine C de Greeff; Angelique G C S Jansen; Hester E de Melker; Leo M Schouls; Eelko Hak; Lodewijk Spanjaard; Elisabeth A M Sanders; Arie van der Ende
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

10.  Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.

Authors:  Dylan R Pillai; Dea Shahinas; Alla Buzina; Remy A Pollock; Rachel Lau; Krishna Khairnar; Andrew Wong; David J Farrell; Karen Green; Allison McGeer; Donald E Low
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.